Conic Finance (CNC) news

BUZZ-Humana shares rise on improved “Federal Medicare Advantage Plan” ratings

October 9 – Humana Inc (HUM.N) shares surged 14.4% in pre-market trading to $443. According to U.S. government data, 95% of HUM members participating in the “Medicare Advantage Plan” were rated four stars or higher for 2027. Higher star ratings are crucial for insurance companies, as they result in government bonuses and can boost plan enrollment. Oppenheimer analysts estimate the improved ratings could add $3.6 billion in revenue for the company. In contrast, according to Oppenheimer, competitors UnitedHealth Group (UNH.N) and CVS Health (CVS.N) saw their average ratings fall by 15% from last year, while Elevance (ELV.N) and Centene (CNC.N) also experienced declines. As of the previous trading session, HUM had gained 51% year-to-date, while UNH, CVS, and ELV posted gains between 10% and 14.4%, and CNC surged 57%.

Centene to redeem remaining USD 568.66 million notes on Oct. 23

Centene issued a redemption notice for all remaining USD 568.66 million of its 4.25% Notes due Dec. 15, 2027. Redemption date set for Oct. 23, 2026, eliminating the 2027 Notes from Centene’s outstanding debt. Redemption price set at 100% of principal, with accrued and unpaid interest to, but excluding, Oct. 23, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centene Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001071739-26-000186), on October 08, 2026, and is solely responsible for the information contained therein.

Hedge fund tycoon David Einhorn: Gold will significantly outperform the Nasdaq in the next 3-5 years

David Einhorn believes that the US fiscal situation is out of control, the reserve status of the US dollar is being eroded, and the ongoing trend of de-dollarization continues to strengthen the long-term value of gold. Gold is the largest macro long position for Greenlight Capital. Meanwhile, he warns that the major tech giants currently dominating the Nasdaq are shifting from a light-asset monopoly model to capital-intensive competitive businesses. The depreciation pressure brought by AI capital expenditures will gradually erode profits.